CAIM
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

CAIM Trademark

Serial Number: 86290520

CAIM is a trademark filed by The Translational Genomics Research Institute on May 23, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

The Translational Genomics Research Institute (42 trademarks)

Phoenix, AZ 85004

Entity Type: 03

Trademark Details

Filing Date

May 23, 2014

Registration Date

Not Registered

Published for Opposition

June 9, 2015

Goods & Services

Consulting services in the field of medical education, namely, providing education and training information relating to the identification, diagnosis and treatment of medical and genetic conditions; Education services, namely, providing live and on-line continuing professional education seminars in the medical, scientific and genetics field; Education services, namely, providing training programs in the field of genetics; Conducting workshops and seminars in genetic testing and disease identification and treatment; Educational services, namely, organization of seminars educational conference attendee working groups and research groups and conventions in the fields of medicine, genetics and scientific research; On-line journals, namely, blogs featuring commentary and information in the fields of DNA identification techniques, practices, and tools; Organization of educational conferences and symposia for the discussion, dissemination and exchange of scientific data and ideas on topics of interest to the scientific community; Providing educational demonstrations regarding biology, molecular biology, genetics, DNA sequencing and bioinformatics; Conducting classes, seminars and workshops in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study and distributing course materials in connection therewith; Educational services, namely, conducting educational programs in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Educational services, namely, conducting on-line exhibitions and displays and interactive exhibits in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Organizing exhibitions for education in biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Providing courses of instruction in the fields of biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study and distributing course material in connection therewith; Teaching in the fields of biology, molecular biology, genetics, genomics, DNA sequencing and bioinformatics and nature study

Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting mutation in prion genes for medical purposes; Clinical diagnostic preparations for medical use; Chemical reagents for medical analysis; Chemical diagnostic preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of immunotherapy, and for identifying and characterizing immune dysfunction

Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Genetic identity tests comprised of reagents; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties for scientific and research use

Diagnosis and treatment of medical conditions; Genetic testing for diagnostic purposes; Genomic testing for diagnostic purposes; Medical testing for diagnostic or treatment purposes in the field of cancer research; Medical diagnostic testing, monitoring and reporting services; Medical evaluation services; Medical monitoring services; Medical diagnostic, prognostic and theranostic screening and testing; Collection and preservation of DNA for medical purposes; Consulting services in the field of healthcare and cancer diagnoses; Providing a website featuring health and healthcare information related to cancer research, testing and screening; Genetic testing for medical purposes; Providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; Providing genetics assessments in the nature of genetic counseling; Molecular profiling services of patients for use in providing medical and related health care services to patients

Conducting medical and scientific educational research for others on the subjects of biology, molecular biology, genetics, genomics, DNA sequencing, and bioinformatics; Medical and scientific research in the field of genetic testing; Development and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, DNA sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; DNA collection, testing and analysis services for scientific research purposes; Medical and scientific research, development and scientific consulting in the field of oncology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for medical and scientific research purposes; Medical and scientific research relating to the design and development of cancer treatment therapies; Conducting clinical and pre-clinical trials for others; Diagnostic services for equipment in the field of molecular science, comparative genome analysis, DNA arrays and screening of nucleic acids; Research and development of identification and treatment methods for hereditary factors leading to disease; Testing and evaluation for scientific purposes, namely, identification of target molecules for cancer treatment; Testing and evaluation for scientific purposes, namely, proteogenomic profiling; DNA-sequencing for scientific research purposes; Targeted pharmaceutical drug development services; Testing and evaluation for scientific purposes, namely, genotyping; Testing and evaluation for scientific purposes, namely, gene screening; Gene isolation and gene expression analysis for scientific research purposes; Testing and evaluation for scientific purposes, namely, gene mapping; Gene analysis and biomarker discovery for scientific research purposes; Collection and preservation of DNA for research purposes

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Mar 13, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 13, 2017 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 7, 2016 EXRA
SOU EXTENSION 2 GRANTED
Sep 6, 2016 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 27, 2016 AITU
SOU EXTENSION 2 FILED
Aug 4, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 4, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 30, 2016 EXRA
SOU EXTENSION 1 GRANTED
Jan 28, 2016 EX1G
SOU EXTENSION 1 FILED
Jan 28, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 28, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 4, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 1, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
May 1, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 1, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
May 1, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 1, 2015 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 30, 2015 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 14, 2015 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 28, 2015 PREV
ASSIGNED TO LIE
Mar 28, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2015 CNSA
ASSIGNED TO EXAMINER
Mar 6, 2015 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2015 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 24, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 24, 2015 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 15, 2014 GNRN
NON-FINAL ACTION E-MAILED
Sep 15, 2014 GNRT
NON-FINAL ACTION WRITTEN
Sep 15, 2014 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 6, 2014 NWOS